Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3858326 | 0.79 | MAPK1 (0.35) | KCNN4ALDH1A1CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL692188 | 0.67 | CYP1A2 (0.33) | CYP1A2CYP2D6 | |
| SCHEMBL28284969 | 0.67 | CYP1A2 (0.37) | TSHRKCNN4ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL134389 | 0.65 | MIF (0.40) | TSHRCYP2D6 | |
| SCHEMBL43325 | 0.65 | SRC (0.42) | TSHRALDH1A1CYP2D6 | |
| SCHEMBL165792 | 0.65 | MIF (0.40) | TSHRCYP2D6 | |
| SCHEMBL15413 | 0.65 | KCNN4 (0.36) | TSHRKCNN4ALDH1A1CYP1A2PTPN1 | |
| SCHEMBL129231 | 0.65 | KCNN4 (0.36) | TSHRKCNN4ALDH1A1CYP1A2PTPN1 | |
| SCHEMBL1149592 | 0.65 | KCNN4 (0.36) | TSHRKCNN4ALDH1A1CYP1A2PTPN1 | |
| SCHEMBL20146 | 0.65 | MIF (0.40) | TSHRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4326795-A1 | POLYMERIZATION OF A SILANE-MODIFIED POLYMER, WHICH IS PRODUCED BY MEANS OF A RADICAL CHAIN POLYMERIZATION, IN A POLYOL OR IN A PREPOLYMER WITH TERMINAL ISOCYANATE GROUPS, AND USE THEREOF IN POLYURETHANE FORMULATIONS | Follmann GmbH & Co. KG (DE) | 2024-02-28 | — | — | EP | disclosed |
| US-11261288-B2 | Allyl functional urethane oligomers and related compositions for coatings and adhesives | ARKEMA FRANCE (FR) | 2022-03-01 | — | — | US | disclosed |
| US-20200392280-A1 | ALLYL FUNCTIONAL URETHANE OLIGOMERS AND RELATED COMPOSITIONS FOR COATINGS AND ADHESIVES | ARKEMA FRANCE (FR) | 2020-12-17 | — | — | US | disclosed |
| US-7105262-B2 | Liquid developer | SEIKO EPSON CORPORATION (JP) | 2006-09-12 | — | — | US | disclosed |
| EP-1660117-A2 | USE OF SECRETAGOGUES LIKE GHRELIN IN CANCER CACHEXIA AND FOR STIMULATING APPETITE | Gastrotech Pharma A/S (DK) | 2006-05-31 | — | — | EP | disclosed |
| CN-1248061-C | Dry toner and producing method thereof | SEIKI EPSON CO LTD (JP) | 2006-03-29 | — | — | CN | disclosed |
| WO-2005014032-A2 | USE OF SECRETAGOGUES LIKE GHRELIN IN CANCER CACHEXIA AND FOR STIMULATING APPETITE | GASTROTECH PHARMA A/S (DK) | 2005-02-17 | — | — | WO | disclosed |
| US-20050003293-A1 | Liquid developer | SEIKO EPSON CORPORATION | 2005-01-06 | — | — | US | disclosed |
| CN-1337602-A | Dry toner and producing method thereof | SEIKI EPSON CO LTD (JP) | 2002-02-27 | — | — | CN | disclosed |